Head and Neck Squamous Cell Carcinoma (HNSCC) research hub

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

This study is looking at a new drug, GTAEXS617, for people with advanced solid tumours, including certain types of breast, lung, head and neck, and ovarian cancers. We want to see how safe it is, how the body handles it, and if it can shrink tumours.